1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

04 Aug 2021
Admin
News Article

Wuxi Sta Completes Acquisition Of Bristol Myers Squibb Manufacturing Facility In Couvet Switzerland

Wuxi Sta &Ndash; A Subsidiary Of Wuxi Apptec &Ndash; Today Announced That It Has Completed The Acquisition Of A Drug Product Manufacturing Facility In Couvet, Switzerland From Bristol Myers Squibb (Nyse: Bmy). Wuxi Sta First Announced Its Plans To Purchase The Facility Earlier This Year. The Acquisition Will Enhance Wuxi Sta&Rsquo;S Capabilities By Adding Capacity To Support Its Global Partners In Bringing Innovative Medicines To Patients Around The World.The Couvet Site Is The First Facility In Europe For Wuxi Sta. Opened In 2018, This Facility&Rsquo;S State-Of-The-Art Tablet &Amp; Capsule Manufacturing And Packaging Capabilities Will Provide Wuxi Sta&Rsquo;S Customers More Flexibility Thanks To An Enhanced Supply Of Global Drug Product And Greater Access To The European Market And Beyond.By Enhancing Its Network, Wuxi Sta Can Better Support Customers&Rsquo; Long-Term Needs Globally As They Bring New And Existing Commercial Manufacturing Projects From Their Pipelines To The Facility With The Capability And Capacity To Supply Drug Products To Major Global Markets.&Ldquo;We Are Delighted To Have Added The Couvet Site To Our Global Supply Network And Are Excited To Welcome Its Highly Skilled Team To The Wuxi Sta Family,&Rdquo; Said Dr. Minzhang Chen, Co-Ceo Of Wuxi Apptec. &Ldquo;Through Combining Resources Of The Couvet Site With Our Other Facilities, We Continue Strengthening And Broadening Our Capacity And Capabilities To Better Support Our Global Customers In Delivering Innovative Medicines To Patients In Need.&Rdquo;Through This Transaction, Wuxi Sta Has Increased Its Global Presence To Eight R&Amp;D And Manufacturing Sites Across Asia, North America And Europe, Including The Recently Announced Middletown Site In Delaware Of The United States.-Ends- About Wuxi StaWuxi Sta (Stapharma.Com), A Subsidiary Of Wuxi Apptec (Wuxiapptec.Com), Is A Leading Pharmaceutical Development And Manufacturing Capability And Technology Platform Company Serving The Life Sciences Industry, With Global Operations. As A Premier Contract Development And Manufacturing Organization (Cdmo), Wuxi Sta Offers Its Worldwide Partners Efficient, Flexible And High-Quality Solutions For Integrated Chemical, Manufacturing And Control (Cmc) From Preclinical To Commercial Uses.For More Information, Please Visit: Http://Www.Stapharma.ComAbout Wuxi ApptecWuxi Apptec Provides A Broad Portfolio Of R&Amp;D And Manufacturing Services That Enable Companies In The Pharmaceutical, Biotech And Medical Device Industries Worldwide To Advance Discoveries And Deliver Groundbreaking Treatments To Patients. As An Innovation-Driven And Customer-Focused Company, Wuxi Apptec Helps Our Partners Improve The Productivity Of Advancing Healthcare Products Through Cost-Effective And Efficient, Socially Responsible And Sustainable Solutions. With Industry-Leading Capabilities Such As R&Amp;D And Manufacturing For Small Molecule Drugs, Cell And Gene Therapies, And Testing For Medical Devices, Wuxi Apptec'S Open-Access Platform Is Enabling More Than 4,400 Collaborators From Over 30 Countries To Improve The Health Of Those In Need &Ndash; And To Realize Our Vision That "Every Drug Can Be Made And Every Disease Can Be Treated." Please Visit: Www.Wuxiapptec.Com

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!